USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
25 Jan 2022 | 03:45 PM GMT

Digital Health for Depression & Anxiety: Evidence & Adoption

Anchored by:

Aahuti Rai
NED, Advisor & Venture Partner
FOUR POINTS HEALTH | CONDUIT CONNECT

Participants:

Aahuti Rai NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Aahuti Rai
NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Ahmed Albaiti PrincipalZS
Ahmed Albaiti
PrincipalZS
Chris Wasden Chief Strategy OfficerTwill
Chris Wasden
Chief Strategy OfficerTwill
Christopher Hall Commercial Director, APACMarula Health
Christopher Hall
Commercial Director, APACMarula Health
Grace McNamara CEOEXi
Grace McNamara
CEOEXi
Jeff Weness VP Growth and StrategyRefinedScience
Jeff Weness
VP Growth and StrategyRefinedScience
Jonas Duss Principal / Founder1sourcehealth.com
Jonas Duss
Principal / Founder1sourcehealth.com
Molly Coye Board MemberHeadspace Health
Molly Coye
Board MemberHeadspace Health
Richelle Flanagan Co-FounderMy Moves Matter
Richelle Flanagan
Co-FounderMy Moves Matter
Steffanie Bristol Head, Biogen Digital Health VenturesBiogen
Steffanie Bristol
Head, Biogen Digital Health VenturesBiogen
Tim Juergens PartnerCrossroad Biotech
Tim Juergens
PartnerCrossroad Biotech

About this Meeting


Are you working on digital health solutions for depression and/or anxiety? Keep reading, this meeting is for you.   

Depression and anxiety are two of the most prevalent mental health conditions, affecting hundreds of millions of people worldwide. However, not everyone gets the treatment they need due to the shortage of professionals, accessibility, late diagnosis and the social stigma. There is a wide range of digital health solutions that can help in all these areas; in this meeting we will focus on their clinical evidence and adoption: 

Clinical evidence:  
  •  Do digital health solutions improve clinical outcomes in depression & anxiety? Is it enough to get physicians and psychologists buy-in?
  •  Most solutions use digitized CBT, but what is the clinical evidence of new purely digital solutions like Virtual Reality (VR) or Neuromodulation? 

 Adoption and last-mile delivery challenges:
  • Industry perception and reception of these products (patients, physicians & psychologists’ engagement) and last-mile distribution challenges.  
  •  Types of digital health solutions with the highest adoption